PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment

Dallas, TX, March 31, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse report, “The Amylin Renaissance: Forty Programs, $19 Billion in Deals, and the Race to Build the Next Pillar of Obesity Medicine.”